Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Credit Suisse Downgrades Banco Santander Chile to Neutral

Credit Suisse Downgrades Banco Santander Chile to Neutral

Credit Suisse analyst Alonso Garcia downgrades Banco Santander Chile (NYSE:BSAC) from Outperform to Neutral.

byBenzinga Newsdesk

August 19, 2022

1 minute read

Credit Suisse analyst Alonso Garcia downgrades Banco Santander Chile (NYSE:BSAC) from Outperform to Neutral.

P/E Ratio Insights for ONEOK

By Benzinga Insights

November 23, 10:45 AM

In the current market session, ONEOK Inc. (NYSE:OKE) stock price is at $66.70, after a 0.31% decrease. However,…

OKE

Why Modular Medical Shares Are Trading Higher By 34%; Here Are 20 Stocks Moving Premarket

By Lisa Levin

August 17, 8:15 AM

Gainers Modular Medical, Inc. (NASDAQ: MODD) shares surged 34.3% to $1.37 in pre-market trading after the company announced a partnership with Phillips-Medisize to expand insulin delivery alternatives.

AHI

Analyst Ratings

The Latest Analyst Ratings for Silence Therapeutics

By Benzinga Insights

May 11, 2:00 PM

Over the past 3 months, 4 analysts have published their opinion on Silence Therapeutics (NASDAQ:SLN) stock. These analysts…

SLN

Analyst Ratings

Navigating 5 Analyst Ratings For CareDx

By Benzinga Insights

May 13, 5:00 PM

Throughout the last three months, 5 analysts have evaluated CareDx (NASDAQ:CDNA), offering a diverse set of opinions from…

CDNA

Credit Suisse Downgrades Banco Santander Chile to Neutral

Related Posts

P/E Ratio Insights for ONEOK

Why Modular Medical Shares Are Trading Higher By 34%; Here Are 20 Stocks Moving Premarket

The Latest Analyst Ratings for Silence Therapeutics

Navigating 5 Analyst Ratings For CareDx